Immunoprecipitation and MS has been performed to emphasize CK5 interacting proteins in ER+ BC cells, identifying that the blockade of CK5-β-catenin interaction may reverse the detrimental proprieties of CK5+ breast cancer cells [92]. The gene discussed is KRT5; the disease is breast carcinoma.